Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilmott

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Nature Communications|May 17, 2020
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumoursPeter A Johansson, Kelly Brooks, Felicity Newell, et al.
Nature Medicine|February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastomaGeorgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
The Journal of Clinical Investigation|May 4, 2021
The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamicsWilliam Giblin, Lauren Bringman-Rodenbarger, Angela H Guo, et al.
Cancer Discovery|September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma SubtypesFelicity Newell, Peter A Johansson, James S Wilmott, et al.
Frontiers in Oncology|January 22, 2019
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous MelanomaXiaobei Zhao, Paul Little, Alan P Hoyle, et al.
Nature Communications|July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targetsFelicity Newell, Yan Kong, James S Wilmott, et al.
Nature|March 31, 2022
Anatomic position determines oncogenic specificity in melanomaJoshua M Weiss, Miranda V Hunter, Nelly M Cruz, et al.
Immunity|October 14, 2020
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8<sup>+</sup> T CellsMatthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, et al.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Nature|May 4, 2017
Whole-genome landscapes of major melanoma subtypesNicholas K Hayward, James S Wilmott, Nicola Waddell, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Nature Communications|May 17, 2020
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumoursPeter A Johansson, Kelly Brooks, Felicity Newell, et al.
Nature Medicine|February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastomaGeorgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
The Journal of Clinical Investigation|May 4, 2021
The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamicsWilliam Giblin, Lauren Bringman-Rodenbarger, Angela H Guo, et al.
Cancer Discovery|September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma SubtypesFelicity Newell, Peter A Johansson, James S Wilmott, et al.
Frontiers in Oncology|January 22, 2019
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous MelanomaXiaobei Zhao, Paul Little, Alan P Hoyle, et al.
Nature Communications|July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targetsFelicity Newell, Yan Kong, James S Wilmott, et al.
Nature|March 31, 2022
Anatomic position determines oncogenic specificity in melanomaJoshua M Weiss, Miranda V Hunter, Nelly M Cruz, et al.
Immunity|October 14, 2020
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8<sup>+</sup> T CellsMatthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, et al.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Nature|May 4, 2017
Whole-genome landscapes of major melanoma subtypesNicholas K Hayward, James S Wilmott, Nicola Waddell, et al.
Pageof 17